F atty infiltration of the liver or steatosis is a common indicator of hepatocellular lesion secondary to a variety of etiologies. One of the most common causes of steatosis in developed countries is nonalcoholic fatty liver disease (NAFLD), mainly characterized by the occurrence of macrovesicular steatosis in the absence of significant alcohol consumption. Nonalcoholic fatty liver disease encompasses a broad range of histological lesions, from isolated steatosis to nonalcoholic steatohepatitis (NASH), in which steatosis is associated with various degrees of inflammation, fibrosis, and ballooning degeneration of hepatocytes. The pathogenesis of NAFLD is multifactorial, in the context of the so-called metabolic syndrome, 1 combining obesity, diabetes, hypertension, and hypertriglyceridemia, 2 and associated with insulin resistance. So far, liver biopsy is required when an assessment of activity and severity of NAFLD is considered necessary.
In the United States, approximately 47 million individuals are estimated to have a metabolic syndrome 3 : fatty infiltration of the liver can be detected in up to 12% to 15% in this population, 4 and 3% to 4% of patients with NAFLD have steatohepatitis. Nonalcoholic steatohepatitis was originally believed to be a benign disease. However, it has been recently shown that NASH could lead to irreversible liver disease in some patients. 5 In addition, when another liver disease is present, coexistent steatosis may exacerbate liver injury by acting as a cofactor. Therefore, the diagnosis of steatosis does have important therapeutic implications, because active management of obesity and a reduction in steatosis may improve liver injury and decrease the progression of fibrosis. This prompts a considerable interest in the development of noninvasive methods for the detection and quantification of the fatty infiltration of the liver in the context of NAFLD. Moreover, after a first biopsy to diagnose NAFLD or NASH, a noninvasive, safe, reproducible technique of quantification could allow for the evaluation of the effects of NAFLD treatment without the need of a liver biopsy. In such indications, not only qualitative but also quantitative information would be important.
It has been shown that several noninvasive techniques such as ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI) can detect liver steatosis. Ultrasonography is widely used to detect hepatic steatosis, but its sensitivity is reduced in patients with small amounts of fatty infiltration; moreover, it cannot provide reliable quantitative data. Unenhanced CT can detect and characterize macroscopic fat in the liver using liver-to-spleen attenuation difference with excellent correlation in patients with more than 30% of steatosis; however, the feasibility and reliability of a quantitative evaluation with this method remain to be demonstrated.
The purpose of the present study was therefore to determine the accuracy of MRI in the detection and quantitative assessment of the extent of liver steatosis, as compared with histological evaluation.
MATERIALS AND METHODS

Patient Selection and Study Design
This was a prospective single-institution study. The study protocol was approved by the human research committee of our institution. After the risks and possible benefits of the procedure were fully explained, all patients gave written informed consent and signed an institutional review boardYapproved, Health Insurance Portability and Accountability ActYcompliant consent form before MRI. Forty asymptomatic patients (20 women and 20 men; mean age, 52.5 years; range, 23Y78 years), with an incidentally discovered elevation of liver enzymes, no history of excessive alcohol intake, negative results of viral screening, and no liver mass at US, were referred for liver biopsy for diagnostic purposes between April 2007 and February 2008 and were included in the study.
Clinical Data Collection
Physical Examination
Body measurements included weight and standing height at the time of liver biopsy. Body mass index (BMI, kilograms per square meter) was calculated from these values. Obesity was defined as a BMI 30 kg/m 2 or more and overweight as a BMI 25 kg/m 2 or more for a man or 24 kg/m 2 or more for a woman.
Associated Diseases
The occurrence of diabetes, arterial hypertension, hyperlipidemia, and/or regular alcohol consumption was checked for.
Laboratory Assessments
Biological data including hematological parameters, liver function tests, coagulation tests, renal parameters, and fast blood glucose and lipid profiles were obtained the same day than liver biopsy.
Magnetic Resonance Imaging
Magnetic Resonance Imaging Technique
Magnetic resonance imaging and liver biopsy were performed the same day, and to avoid postYbiopsy artifacts, MRI was the first procedure to be performed. 
Image Interpretation
One radiologist (N.M.) who was unaware of clinical examination, history, and pathological results interpreted MR examinations on a picture archive and communication system workstation (Impax; Agfa, Mortsel, Belgium) by using qualitative and quantitative methods to determine the presence and degree of hepatic steatosis.
Qualitative Assessment
Overall image quality was evaluated subjectively. The presence of fatty infiltration was determined based on characteristic signal features, recognized as regions of the liver that demonstrated a decrease in signal intensity (SI) on OP images as compared with IP images. The spleen and skeletal muscle were used as reference tissues for SI changes because they are known to contain little intracellular lipid.
Region-of-Interest Analysis
Signal intensity from regions of interest in the liver was recorded for T1-weighted IP and OP GRE sequences. Three different regions of interest were drawn in liver segments 5, 7, and 8 for each patient. These regions of interest were drawn so as to be more than 1.5 cm 2 to include representative areas of parenchyma that did not contain blood vessels or an artifact and to be potentially at a similar location and depth of the liver biopsies. For each sequence, the region of interest in the liver parenchyma was matched on the same location, taking care to avoid areas with vessels and motion artifacts. The SI of the liver was recorded as the mean of the 3 regions of interest. Fat-water ratio was quantified on T1-weighted GRE MRIs as the percentage of relative SI loss of the liver on OP images, with the following formula: (SI in Y SI out) / (SI in + SI out), as SI out denotes out-ofphase SI, and SI in denotes IP SI, where SI in = W + F and SI out = W j F (W and F denote water and fat vectors, respectively).
Histopathology
Percutaneous liver biopsies were performed with a 14-gauge needle, under US guidance, along the midaxillary line, in variable segments in the right hepatic lobe. All biopsies were 1.5 cm or more in length. Tissue samples were fixed in buffered formalin and embedded in paraffin. Sections, 4 Km thick, were stained with hematoxylin-eosin-saffron, Perls iron stain, and chromotrope and evaluated by one pathologist. The histopathological evaluation was performed masked from any clinical information. Furthermore, liver steatosis was reported as a quantitative evaluation of the percentage of hepatocytes (0%Y 100%), containing macrovesicular fat (fat droplets equal to or larger than the size of the nucleus, often displacing the nucleus) or microvesicular fat (numerous small fat droplets surrounding a centrally located nucleus). The following grading system was used for reporting: grade 0, less than 5% of steatotic hepatocytes; grade 1, 6% to 33%; grade 2, 34% to 66%; and grade 3, greater than 66%. In addition, the distribution of steatosis within the lobule (zone 3 predominant, zone 1 predominant, panlobular, and azonal) was noted. Fibrosis was evaluated on chromotrope-stained slides according to the Brunt classification 6 : 0 (none), 1 (perinusoidal or portal/periportal), 2 (perisinusoidal and portal/periportal), 3 (bridging fibrosis), and 4 (cirrhosis). A diagnostic of NASH was considered when the NAFLD activity score (NAS; Table 1 ), as previously defined, 7 was more than 5.
Statistical Analysis
To determine whether MRI could be able to give a quantitative evaluation of the extent of hepatic steatosis, hepatic fat fraction and fat-water ratio were correlated with the histological degree of steatosis by using a linear regression analysis and Pearson correlation coefficient (r) (XL stat-Pro for Excel; Addinsoft, Paris, France). The degree of steatosis, as determined by the pathologist, was used as a continuous variable in the regression models because the value of the hepatic fat fraction and the fatwater ratio that were calculated by using the MRIs was a continuous variable.
The overall diagnostic performance of diagnosis of liver steatosis was compared with that of fat-water ratio by receiver operating characteristic analysis. A receiver operating characteristic curve was produced to demonstrate the sensitivity and specificity of this parameter in our population and has been used to assess the accuracy of the dual fast GRE as a diagnostic test in liver steatosis using a threshold value of 5% for the pathological analysis and 20% in case of surgical approach.
RESULTS
Clinical and Biological Results
The final diagnoses of the conditions of the patients in the study group (as assessed from the combination of clinical, biological, and histological data) were NAFLD in 18 patients (including 10 patients with NASH), alcoholic steatohepatitis in 9, cholangiopathy in 3, autoimmune hepatitis in 4, drug-induced steatohepatitis in 1, hemochromatosis in 1, and cryptogenetic liver disease in 4.
An elevated BMI was present in 29 (72.5%) of 40 patients. From these patients, 17 (58.6%) had a diagnosis of NAFLD. The mean (SD) BMI values were 32 (7.5) kg/m 2 in patients with NAFLD and 26 (4.4) kg/m 2 in others. Mean aspartate aminotransferase level was 60.2 UI/L (n = 10Y45), and mean alanine aminotransferase level was 66.4 UI/L (n = 10Y45). Mean bilirubin level was 32.9 Kmol/L (n G 20). Mean triglyceride level was 4.8 mmol/L (n G 2), and mean cholesterol level was 5.8 mmol/L (n = 3.5Y6.5). Diabetes was diagnosed in 12 (60%) of the patients with NAFLD and 25% of the others.
Histological Results
Liver steatosis was present in 33 patients (82.5%). Histological gradings were 0 in 7 patients, 1 in 10 patients, 2 in 12 patients, and 3 in 10 patients ( Table 2 ). The mean (SD) percentage of steatosis was 38.7% (29.2; range, 0%Y90%). Macrovesicular steatosis was present in 26 patients (79%) and microvesicular steatosis in 2 patients (6%); an association of macrovesicular and microvesicular steatoses was observed in 5 patients (15%). Thirty-six patients presented with liver fibrosis: score 1 in 17 patients (42.5%), score 2 in 9 patients (22.5%), score 3 in 4 patients (10%), and score 4 in 6 patients (15%). Ten patients with NAFLD (50%) had a NAS of 5 or greater and were therefore considered to have NASH (Table 1) .
Magnetic Resonance Imaging Results
T1-weighted IP and OP GRE sequences were obtained in all 40 patients; there were no cases of technical failure in this series. Dropout SI on T1-weighted OP GRE sequence was identified in 37 patients.
The mean (SD) fat-water ratio of SI between T1-weighted OP and IP images was 0.196 (0.075; P G 0.0001). The mean (SD) fat-water ratios were 0.31 (0.22) in the subgroup of patients with histological evidence of fatty liver infiltration and 0.00 (0.06) in the subgroup of patients without liver fatty infiltration at histological examination (P G 0.0001). We then compared the median fat-water ratio according to the histological grade of steatosis: j0.014 (j0.013 to 0.027) for grade 0; 0.026 (0.001 to 0.150) for grade 1; 0.243 (0.065 to 0.313) for grade 2; and 0.506 (0.185 to 0.694) for grade 3. The differences were statistically significant between grades 0 and 1 (P G 0.01), grades 1 and 2 (P G 0.01), and grades 2 and 3 (P G 0.01).
At individual level, the fat-water ratio was strongly correlated with the histological evaluation of steatosis (P G 0.0001), the coefficient of linear regression corresponding to r = 0.852 (Fig. 1) . The relation between the histological degree of steatosis and the fat-water ratio can therefore be expressed by the following formula: %Steatosis = ((106.6) Â (fat-water ratio)) + 17.8.
Fat-water ratio (cutoff value 9 0) had a sensitivity of 97% and a specificity of 86% for the diagnosis of steatosis greater than 5% (Fig. 2A) . Fat-water ratio (cutoff value 9 0.037) had a sensitivity of 96% and a specificity of 93% for the diagnosis of steatosis greater than 20% (Fig. 2B) .
DISCUSSION
Nowadays, liver biopsy remains the criterion standard for accurately determining, in a semiquantitative manner, the amount of fatty liver infiltration. Furthermore, liver biopsy is able to detect subclinical hepatic pathologies associated with steatosis and contribute to the etiological and differential diagnoses. Liver biopsy is able to evaluate lesions associated with steatosis, such as fibrosis and inflammation, and therefore to evaluate the stage and grade of the disease. However, percutaneous liver biopsy is an invasive procedure and is not devoid from mortality and morbidity. 8 Furthermore, heterogeneity in the distribution and amount of steatosis may be responsible for significant biases of evaluation owing to sampling error.
A reliable noninvasive method for the evaluation of fatty liver infiltration would be a very significant improvement for the screening of patients at risk for liver steatosis such as NAFLD, the long-term monitoring of patients with the disease, and the evaluation of the results of dedicated therapeutic interventions. Our prospective study strongly suggests that MRI should be an interesting tool fulfilling these requirements.
At imaging, the diagnosis of liver steatosis is currently based on qualitative rather than quantitative procedures. Fatty liver infiltration usually appears hyperechoic at US and is of low attenuation compared with normal liver parenchyma at CT, with a range of j10 to j100 HU. On MRI, fat liver appears high in SI on T1-weighted images. 3 In addition, several MRI sequences facilitate in the detection of fat, including fat suppression sequences and chemical shift imaging with OP GRE sequences. 4 At 1.5 T, lipid and water protons precess IP approximately every 4.2 milliseconds (IP imaging), and our signals are additive. Imaging during intermediate echo times of approximately 2.1 milliseconds (OP imaging) leads to phase cancellation effect at a voxel level, resulting in loss of signal in voxel with fat and water. Thus, appropriate selection of echo time can be used to obtain images with differing relative contributions of fat and water signals. In-phase and OP GRE sequences are useful techniques for the diagnosis of diffuse or focal hepatic steatosis.
9Y12 Therefore, we evaluated this simple powerful technique to quantify liver steatosis. The IP and OP images were measured simultaneously with a clinical dual GRE sequence including a breath-holding technique in the same region of the liver. The entire liver with the GRE sequence was scanned in 22 seconds during a breath-hold.
Our results highlight the performances of this MR sequence for the diagnosis and evaluation of liver steatosis (Fig. 3A,B) . For fatty infiltration of more than 20%, sensitivity and specificity of MR fat quantification were 96% and 93%, respectively. This was observed irrespectively of the etiology of the underlying chronic liver diseases: chronic viral hepatitis, alcoholic fatty liver disease, and NAFLD. Our results compare favorably to those reported with other imaging techniques.
According to Saadeh et al, 13 steatosis could be reliably detected, with high sensitivity of 100% and 93% but low positive predictive values of 62% and 76% for US and CT, respectively. Recently, Fishbein et al 14 reported that MRI is superior to US in detecting and quantifying minor degrees of fatty metamorphosis in the liver. Ricci et al, 15 using CT that was performed without contrast material enhancement, reported a correlation coefficient of 0.83 between the percentage of the liver fat and the ratio of the density of the liver to that of the spleen. Limitations of US and CT include the inability to aid in distinguishing between fibrosis and fat with US and the masking effect of factors that increase liver density, such as the presence of iron, copper, glycogen, or amiodarone-induced phospholipidosis, with CT. 16 In addition, CT is difficult to use for quantitative evaluation of fat liver infiltration; this requires specific protocols and depends on the type of CT used, the contrast volume, the injection rate, and the type of contrast used 17, 18 . Finally, classic CT methods, either in terms of[in, of ,for] absolute Hounsfield units of the liver or as liver-to-spleen ratio, may suffer from fluctuations related to the volume, the noise of the patients and the shape of both the liver and spleen.
A simple and reliable tool for fatty liver quantitation remains therefore needed. Our prospective study provides convincing data to validate a noninvasive test that could be used widely in MR clinical study for the assessment of liver steatosis. A significant correlation was found between the degree of steatosis on histological examination and the fat-water ratio on MRI. Furthermore, we demonstrated significant differences in the value of fat-water ratio according to the grade of steatosis at histological examination. Even if the small number of patients included in our study and the heterogeneity of underlying pathologies must be taken into account, the results obtained are highly encouraging and provide a firm basis for stimulating further studies including a larger number of patients. Moreover, our results in a nonselected population of patients are concurrent with those of Rinella et al 10, 11 and more recently Kim et al 12 in one specific indication: predicting the appropriateness of liver donation in candidate living liver donors. These studies concluded that liver biopsy can be obviated in such cases and that donor selection might be more accurate than biopsy because the latter is limited by sampling error (Fig. 3A,B) . A particularly interesting clinical application of MRI would be the monitoring of liver steatosis in patients under targeted medical treatment, parenteral nutrition or after bariatric surgery, without performing iterative liver biopsies. 19, 20 Chemical shift MRI has some technical limitations. This especially includes the ambiguity error. 21 Because the OP images accurately reflect the differences in water and fat signals, it is supposedly not possible to determine whether fat or water is the dominant signal. Although this error should influence measurements in areas with very abundant steatosis, this paradoxical increase in the signal did not occur in our study.
Another point to underline is that fat content is not the only determinant of liver disease. Other factors, which have not been evaluated in this study, such as fibrosis and hepatocellular necrosis, are essential in the progression of chronic liver disease. It is too early to evaluate whether such parameters could be determined in the future by using noninvasive imaging techniques. However, it must be acknowledged that biological markers and scores have been proposed to characterize NAFLD and NASH, with a specific focus on fibrosis and inflammation, rather than steatosis. 22, 23 Recently, Poynard et al 24 evaluated a panel of biomarkers (SteatoTest) for the noninvasive diagnosis of steatosis in patients with or without chronic liver disease. SteatoTest was constructed using a combination of the 6 components of FibroTest-ActiTest, BMI, and serum cholesterol, triglyceride, and glucose levels adjusted for age and sex. The median SteatoTest value was 0.31 in patients without steatosis, 0.39 in grade 1 steatosis (0%Y5%), 0.58 in grade 2 (6%Y32%), and 0.74 in grades 3 and 4 (33%Y100%). It would be interesting to compare the results and the cost/benefit ratio of biochemical techniques with MRI and to evaluate the interest of combining the various noninvasive techniques currently under evaluation in some specific indications.
In conclusion, our study strongly suggests that the comparison of T1-weighted IP and OP GRE images is an efficient method for the diagnosis and quantification of liver steatosis with only 1 short TR series.
